论文部分内容阅读
[目的]观察莫沙必利联合胆石通胶囊治疗≥60岁老年人功能性便秘临床疗效。[方法]将87例≥60岁老年人功能性便秘患者随机分为3组,A组29例,口服莫沙必利5mg、tid;B组28例,口服胆石通胶囊5粒、tid;C组30例,口服莫沙必利5mg、tid,胆石通胶囊5粒、tid;各组疗程均为2周。2周后进行统计,作各组疗效比较分析。[结果]A组、B组、C组的总有效率分别为41.4%、60.7%、93.3%。A组、B组与C组比较均差异有统计学意义(P<0.05)。[结论]莫沙必利联合胆石通治疗老年人功能性便秘临床疗效明显高于单用莫沙必利或胆石通。
[Objective] To observe the clinical efficacy of mosapride combined with gallstone capsule in the treatment of functional constipation in the elderly of ≥60 years old. [Methods] Eighty-seven patients with functional constipation ≥60 years old were randomly divided into three groups: group A, 29 patients, oral mosapride 5mg, tid; group B, 28 patients, oral gitan stone capsule 5, tid; C Group 30 cases, oral mosapride 5mg, tid, gallstone capsule 5, tid; each course of treatment were 2 weeks. 2 weeks after the statistics for the comparative analysis of the efficacy of each group. [Results] The total effective rates of group A, group B and group C were 41.4%, 60.7% and 93.3% respectively. The difference between group A, group B and group C was statistically significant (P <0.05). [Conclusion] The clinical efficacy of mosapride combined with gallstone in treating elderly patients with functional constipation was significantly higher than that of mosapride alone or gallstone alone.